Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 38901 - 38925 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Entinostat	Investigational	VAMP5	10791	upregulated	entinostat results in increased expression of VAMP5 mRNA	2p11.2	A21035
Entinostat	Investigational	VAMP8	8673	upregulated	entinostat results in increased expression of VAMP8 mRNA	2p11.2	A21037
Entinostat	Investigational	VAPA	9218	downregulated	entinostat results in decreased expression of VAPA mRNA	18p11.22	A21037
Entinostat	Investigational	VASH1	22846	downregulated	entinostat results in decreased expression of VASH1 mRNA	14q24.3	A21037 A21035
Entinostat	Investigational	VASH2	79805	upregulated	entinostat results in increased expression of VASH2 mRNA	1q32.3	A21037
Entinostat	Investigational	VAT1L	57687	upregulated	entinostat results in increased expression of VAT1L mRNA	16q23.1	A21037
Entinostat	Investigational	VCAM1	7412	downregulated	entinostat results in decreased expression of VCAM1 mRNA	1p21.2	A21037
Entinostat	Investigational	VCL	7414	upregulated	entinostat results in increased expression of VCL mRNA	10q22.2	A21035
Entinostat	Investigational	VDR	7421	upregulated	entinostat results in increased expression of VDR mRNA	12q13.11	A21035
Entinostat	Investigational	VENTX	27287	upregulated	entinostat results in increased expression of VENTX mRNA	10q26.3	A21037
Entinostat	Investigational	VEPH1	79674	upregulated	entinostat results in increased expression of VEPH1 mRNA	3q25.31-q25.32	A21037
Entinostat	Investigational	VGLL3	389136	upregulated	entinostat results in increased expression of VGLL3 mRNA	3p12.1	A21037
Entinostat	Investigational	VLDLR	7436	downregulated	entinostat results in decreased expression of VLDLR mRNA	9p24.2	A21035
Entinostat	Investigational	VRTN	55237	upregulated	entinostat results in increased expression of VRTN mRNA	14q24.3	A21037
Entinostat	Investigational	VSIG10	54621	upregulated	entinostat results in increased expression of VSIG10 mRNA	12q24.23	A21037
Entinostat	Investigational	VSIG10L	147645	upregulated	entinostat results in increased expression of VSIG10L mRNA	19q13.41	A21035
Entinostat	Investigational	VWA8	23078	upregulated	entinostat results in increased expression of VWA8 mRNA	13q14.11	A21037
Entinostat	Investigational	WASIR2	100132169	upregulated	entinostat results in increased expression of WASIR2 mRNA	16p13.3	A21035
Entinostat	Investigational	WDFY3	23001	downregulated	entinostat results in decreased expression of WDFY3 mRNA	4q21.23	A21035
Entinostat	Investigational	WDFY3-AS2	404201	downregulated	entinostat results in decreased expression of WDFY3-AS2 mRNA	4q21.23	A21037
Entinostat	Investigational	WDR27	253769	downregulated	entinostat results in decreased expression of WDR27 mRNA	6q27	A21037 A21035
Entinostat	Investigational	WDR66	144406	upregulated	entinostat results in increased expression of WDR66 mRNA	12q24.31	A21035
Entinostat	Investigational	WFDC1	58189	upregulated	entinostat results in increased expression of WFDC1 mRNA	16q24.1	A21035
Entinostat	Investigational	WFDC2	10406	upregulated	entinostat results in increased expression of WFDC2 mRNA	20q13.12	A21037 A21035
Entinostat	Investigational	WFDC21P	645638	upregulated	entinostat results in increased expression of WFDC21P mRNA	17q23.1	A21035

Displaying entries 38901 - 38925 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability